892098

Novo Nordisk Pharmaceutical Industries LP — FEI 1000158576

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 21, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Clayton, NC (United States)